For the third in his series of articles for European Hospital, Professor Stefan Schönberg of the Institute of Clinical Radiology and Nuclear Medicine (IKRN), University Hospital Mannheim, Medical Faculty of Mannheim, University of Heidelberg, invited colleagues at the Faculty's Cardiology and Radiology and Nuclear Medicine departments for a round-table discussion on:
The RWTH Aachen University Hospital and the Maastricht University Hospital with their corresponding medical faculties are located centrally in the EU region Meus-Rhine.
A new study from the Saint Louis University found that implantable cardiac devices are not beneficial in patients with advanced heart failure because they are too ill. "Implantable cardiac devices were not intended for, or studied as 'rescue therapy' for very ill hospitalized patients with heart failure," said Paul Hauptman, M.D., professor of internal medicine at Saint Louis University…
On 1st May, Medilog became part of the SCHILLER group. Medilog will be SCHILLER's high-end Holter system. Medilog's additional products are an ideal complement to SCHILLER's present product range. The SCHILLER group very much looks forward to the coming co-operation.
Ian Mason reports from Chicago
Royal Philips Electronics recently announced it will acquire TOMCAT Systems Ltd., based in Northern Ireland. Terms of this acquisition were not disclosed. TOMCAT offers a software solution to collect and aggregate data relative to the cardiac care of patients, and allows for a comprehensive, patient-centric presentation of this data to care givers such as doctors and nurses.
Unexpected risks my result from today's medical devices, such as implantable cardiac defibrillators and pacemakers, if they are equipped with wireless technology to enable remote device checks.
Among its many specialties, the 909-bed AZ Sint-Jan AV Hospital in Bruges, Belgium, has a high level of expertise in cardiac catheterisations and electrophysiology.
Competitive or complementary? By Florian Schwarz BS, Balazs Ruzsics MD PhD and U. Joseph Schoepf MD, of the Radiology and Medicine Departments, at the Medical University of South Carolina, Charleston, USA.
Professor Rémy-Jardin MD PhD heads the Department of Radiology and is Chairman of the Department of Thoracic Imaging at the Calmette Hospital, University Centre of Lille. She is also Professor of Radiology in Lille University's Medical Faculty.
The Visage Thin Client product range on show at the ECR provides a fully-integrated system with advanced tools for 2-D, 3-D, and 4-D image review and interpretation, post-processing, data management, and image distribution.
Agfa Healthcare's new IMPAX solution suites offer PACS and RIS to cover hospital data handling and cardiovascular, cardiology, orthopaedics, mammography and radiology data.
Toshiba America Medical Systems, Inc. introduced the world's first dynamic volume computed tomography system the AquilionONE. This advanced diagnostic imaging system revolutionizes can help reduce diagnosis time for life threatening diseases like stroke and heart disease from days and hours to mere minutes.
The Philips flagship product at RSNA, the 256-slice Brilliance iCT scanner, allows radiologists to produce high-quality images with exceptional acquisition speed, including complete coverage of the heart and brain. It is so powerful it can capture an image of the entire heart in just two beats, while incorporating Philips technology that has reduced radiation doses by up to 80 percent.
Just in time for Medica, VISUS has expanded its products portfolio with a PACS solution for cardiology.
Toshiba's new Artida Ultrasound system is the world's first ultrasound system that can track and display myocardial wall motion three-dimensionally.
Every fourth patient suffering from an irreversible heart defect and due for a heart transplant dies while waiting for a donor organ despite the use of extracorporeal blood pumps. A new ventricular assist device (VAD), currently under development at the German Aerospace Center (DLR), promises a new approach to help these patients. The fully implantable heart support device might be an effective…
The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.
Visage PACS/CS, a scalable PACS solution based on web and thin client technology with fully integrated clinical applications, is to be demonstrated at this year's RSNA in Chicago, along with a comprehensive portfolio of life sciences products and services from Visage Imaging, a subsidiary of Mercury Computer Systems Inc.
According to a study from the technology consultancy Frost & Sullivan the market for CT systems in Europe will grow annually by 4% - in 2013 sales will be worth $1.14 billion. Customers' primary request are cardiac imaging applications, but software innovations and improvements in scan time and image acquisition are also distinguishing features of next-generation systems.
More women than men die of cardiovascular disease (CVD) every year, yet females receive only 33% of angioplasties, stents and bypass surgeries; 28% of implantable defibrillators, and 36% of open heart surgeries.
Switzerland - A clinical trial of cardiac resynchronisation therapy (CRT) in patients with advanced heart failure and a narrow QRS complex
During a meeting of cardiologists in Prague earlier this year to exchange experiences with new methods and treatments to control atrial fibrillation, Dr Josef Kautzner, Head of Cardiology Department at IKEM (Institute of Clinical and Experimental Medicine) pointed out that numbers of patients with AF will more than double during the next 20 years.
The first implant of the Reveal XT, an insertable cardiac monitor made by US firm Medtronic, which recently received CE (Conformité Européenne) Mark, was carried out in June by Professor Karl-Heinz Kuck MD, at the Asklepios Klinik St. Georg in Hamburg, Germany.
Coronary stenting is the most common way of treating symptomatic ischaemic cardiopathy and stenosis of venous bypasses. Restenosis actually occurs in 30% of patients treated with non-medicated stents while "drug eluting" stents have reduced the incidence of restenosis by approximately a quarter and have proved particularly effective in diabetic patients and in the treatment of lesions…